Angelini Ventures
Angelini Ventures opens first Asia regional office in Singapore
Angelini Ventures has officially launched its first Asian regional office in Singapore, positioning itself at the heart of the region's dynamic biotech and healthtech innovation ecosystem.
The expansion reflects the venture capital firm's strategic commitment to scaling disruptive healthcare innovations globally.
This new hun is a natural evolution of our commitment to making healthcare increasingly accessible and patient-centric on a global scale.
Prof. Sergio Marullo di Condojanni,
Asia is an attractive hub for life sciences and biotech innovation. As a venture capital firm focused on biotech and healthtech, we want to be in the epicentre of this growth and Singapore is the ideal location to make it happen.
Paolo Di Giorgio,
Leading the Singapore office, Elia Stupka, Managing Director and Country Head, brings over 20 years of executive experience in healthcare and life sciences.
Stupka highlighted the firm's commitment to data-driven innovation, noting that the Singapore office will leverage Angelini Ventures' proprietary AI-powered Intelligence Hub to identify and accelerate high-potential ventures across the region.
The opening is supported by strategic partnerships with Enterprise Singapore and AI Singapore, establishing collaborative programmes designed to advance biomedical innovation and commercialisation.
[→ Read the full press release]